IFNG and neoplasm: While early IFN-γ signaling promotes anti-tumor immunity via the JAK-STAT-mediated upregulation of MHC I and PD-L1, prolonged signaling may lead to immune suppression and resistance by inducing the expression of inhibitory ligands or epigenetic modifications [199,200].